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This study continues the exploration of the mechanism for the formation of guanidinoacetate and guanidinosuccinate in the human [Clin. Chem. 21, 235 (1975) ]. In this report we describe the formation of canavaninosuccinate from ureidohomoserine and aspartate by a human or bovine liver extract that had high argininosuccinate synthetase (EC 6.3.4.5) activity, and the subsequent formation of guanidinosuccinate by reductive cleavage. In the presence of AlP the optimum pH for the synthetic reaction is 8.4. This reaction can be carried out in either a tris(hydroxymethyl)aminomethane or borate buffer. Subsequent addition of dithiothreitol in the presence of Fe2+ resulted in the cleavage of some of the synthesized canavaninosuccinate to form guanidinosuccinate and homoserine. Synthesis of canavaninosuccinate was strongly inhibited by added argininosuccinate, less so by canavaninosuccinate, arginine, canavanine, glycine, or 2,3-dimercaptopropanol.
The Km values for the substrates of the synthetic reaction are 3.6 X 1O mol/liter for aspartate, 1.6 X iO mol/liter for ureidohomoserine, and 2.92 X iO mol/liter for ATP. These values are higher than those obtained when the synthesis of argininosuccinate was studied, except for AlP, which yielded a lower value. All of the reactions in the proposed mechanism have now been demonstrated except for the synthesis of canaline from aspartate.
In an earlier study, a mechanism was proposed for the formation of guanidinosuccinate as an alternative to guanidinoacetate in human urine (1). The mechanism proposed that two moles of aspartate form canavaninosuccinate, which then acts to produce either guanidinoacetate or guanidinosuccinate, depending upon the biological environment. This mechanism is summarized in Figure 1 . All the reactions, starting with canavaninosuccinate and down to the formation of guanidinoacetate and guanidinosuccinate have been demonstrated in human tissue (1) (2) (3) (4) (5) (6) .
Continuing
this study, it is our objective to explore all of the reactions in the mechanism, in order to investigate the proposal that aspartate may serve as the ultimate raw material for canavaninosuccinate formation.
To do this, we describe here our studies on the synthesis of canavaninosuccinate from ureidohomoserine and aspartate. It should be pointed out that canavaninosuccinate can be synthesized also by the alternative route, which is the reverse of the lyase reaction, where canavanine plus fumarate condense to form canavaninosuccinate (3, 7, 9) . For purposes of our study we followed a method previously described for the purification of argininosuccinate synthetase (EC 6.3.4.5) Dialyze the entire solution against potassium phosphate buffer (5 mmol/liter, pH 7.5) as before. Add 4 ml of argininosuccinate (200 mmol/liter) and 27 ml of the phosphate buffer to adjust the protein concentration to 22 g/liter. Add 3.5 g of bentonite (Sigma), stir intermittently for 10 mm, and centrifuge for 5 mm. To the supernate add 0.7 ml of argininosuccinate (200 mmol/liter) and place the mixture in a 61 #{176}C water bath for 7 mm while stirring rapidly. Chill quickly in ice and remove any denatured protein by centrifugation.
Precipitate the protein in the supernate (76 ml) with 41.5 g of (NH4)2S04.
Centrifuge, and dissolve the precipitate in 5 ml of tris(hydroxymethyl)aminomethane (Tris) buffer (0.1 mol/liter, pH 7.8). Store in 1-ml fractions at -20 #{176}C.
Dialyze a 1-ml fraction against Tris buffer (20 mmol/liter, pH 7.8) for 4 h, and dilute to 7.5 ml with the same buffer. Prepare DEAE-cellulose for use by washing with water, 0.1 mol/liter NaOH, and water again. Equilibrate with Tris buffer (0.2 mol/liter, pH 7.9) and wash with Tris buffer (20 mmol/liter, pH 7.8). Add the diluted enzyme solution to a 1 X 20 cm column containing DEAE-cellulose, elute with Tris buffer (20 mmol/liter, pH 7.8), and collect 6-ml fractions. The enzyme emerges in tubes 3 through 9. Treat the 42-ml pool with 26 g of (NH4)2S04, mix, and let stand overnight.
Centrifuge, dissolve the precipitate in 1 ml of Tris buffer (0.1 mol/liter, pH 7.5), and store at -20 #{176}C. Our enzyme solution prepared in this way contained 31 mg of protein per milliliter and generated 0. Add to 0.125 
Results
At the left of Figure 2 are the electrophoretic patterns that visually demonstrate canavaninosuccinate synthesis from aspartate and ureidohomoserine in the presence of a liver extract. At the outset, only the aspartate (moving toward the anode) and ureidohomoserine (moving toward the cathode) stains are seen. The protein in the mixture is stained lightly near the origin. After 1 h of incubation, the concentration of both substrates has been decreased and a substantial amount of canavaninosuccinate (moving toward the anode) has appeared.
The right half of Figure 2 demonstrates argininosuccinate synthesis from aspartate and citrulline in the presence of a liver extract. At the outset aspar- Fig. 3. Optimum-pH curve tase from human liver for canavaninosuccinate synthetate (moving toward the anode) and citrulline (moving toward the cathode) are visible. After 1 h of incubation, the concentration of both substrates has been markedly decreased, and argininosuccinate (moving toward the anode) has appeared. Figure 3 , the optimum pH curve for canavaninosuccinate synthesis, shows the optimum pH to be 8.4. Similar experiments with argininosuccinate synthesis showed an optimum pH at 8.4 (8, 11) .
Figures 4, 5, and 6 are the Lineweaver-Burk double-reciprocal plots for determining the apparent Michaelis constant for ureidohomoserine, aspartate, and ATP, respectively, in the synthesis of canavaninosuccinate. The rates were determined by a method developed for assaying argininosuccinate synthetase ac- Table 1 lists the effect of selected compounds on the activity of canavaninosuccinate synthetase. These were chosen for reasons discussed below. Statistically significant inhibition was observed with the first six compounds. Dithiothreitol and reduced iipoate were without effect.
When the canavaninosuccinate synthesis reaction mixture was further incubated after the addition of dithiothreitol and Fe2, guanidinosuccinate and some canavaninosuccinate were readily demonstrated to be present with the Sakaguchi reaction after electrophoresis.
DiscussIon
We have demonstrated ( Figure 2 ) the synthesis of canavaninosuccinate from aspartate and ureidohomoserine by human liver extract. The optimum pH for this reaction (Figure 3) is about 8.4, very close to the optimum pH for the reductive cleavage of canavaninosuccinate by lipoate or dithiothreitol and ferrous iron as described previously (3, 4 we have shown a direct synthesis of quanidinosuccinate from ureidohomoserine and aspartate ( Figure  1) .
As has been pointed out before (1), the optimum pH for lyase activity to degrade canavaninosuccinate to form canavanine and fumarate is 6.5. At the pH at which the synthesis proceeds (pH = 8.4) very little lyase activity would be observed. This also serves to preserve the canavaninosuccinate. Incidentally, Figure 2 also shows for the first time, visually, the synthesis of argininosuccinate from citrulline and aspartate.
The Km value shown in Figure 4 for ureidohomoserine, in its condensation with aspartate, is 1.6 X iO.
This should be compared to the Km value for citrulline of 4.53 X 10 that we obtained experimentally in the synthesis of argininosuccinate.
The value we-obtained for citrulline correlates well with a value of 4.6 X 10 reported previously (8, 10), and suggests that ureidohomoserine binds less tightly to the enzyme than does citrulline.
Varying the concentration of aspartate permitted us to obtain the Km value for aspartate, in the presence of ureidohomoserine and ATP, in forming canavaninosuccinate. This is shown in Figure 5 as 3.67 X i0.
For aspartate, in condensation with citrulline in the presence of ATP, we obtained a value of 2.95 X 10. This indicates that aspartate binding to the enzyme system differs when ureidohomoserine is present in place of citrulline. Aspartate then binds more effectively in the presence of citrulline than in the presence of ureidohomoserine.
For ATP, the Km value of 2.92 X 10 was obtained, as shown in Figure 6 , in the synthesis of canavaninosuccinate. A Km of 3.2 X 10 was obtained for ATP in the reaction between citrulline and aspartate to form argininosuccinate (8, 10) . Thus, ATP binds more tightly to the enzyme system when ureidohomoserine and aspartate are present than when citrulline and aspartate are present in the system. Arginine has been reported as an inhibitor of the synthesis of argininosuccinate from asparate and citrulline (10). As indicated in Table 1 , it is also an inhibitor of the canavaninosuccinate synthesis system. It is not unexpected that the product of the reaction, canavaninosuccinate, also acts as an inhibitor of its synthesis. More effective is argininosuccinate, which interferes with synthesis of canavaninosuccinate to an extent greater than 60%. Canavanine, like arginine, also has an inhibitory effect.
Glycine was added on the possibility that if some of the formed canavaninosuccinate were converted to canavanine, it would transamidinate to glycine, thus removing a product of the reaction and acting as a stimulus for the reaction. In the presence of transaminidase, glycine activates canavaninosuccinate lyase activity
(1). In the purified enzyme system, which had no transamidinase activity, glycine actually acts as an inhibitor, as can be seep in Table 1 This may explain the fact that approximately a 10% inhibition of the system was observed when 2,3-dimercaptopropanol was added to the reaction mixture.
We have now demonstrated that all of the reactions shown in Figure 1 are operative in the human except the formation of canaline or ureidohomoserme. To complete this study, we are now exploring the mechanism for the formation of canaline.
